Enumeral Biomedical Holdings, Inc. Research and Development Expense
Enumeral Biomedical Holdings, Inc. reported Research and Development Expense of $90.82 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-11-14
- Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2017-09-30 was $90.82K, a 91.15% decline year-over-year.
- Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2017-06-30 was $883.34K, a 28.81% decline year-over-year.
- Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2017-03-31 was $1.15M, a 22.04% decline year-over-year.
- Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2016-12-31 was $1.13M, a 32.05% decline year-over-year.
- Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2016 was $4.87M, a 25.08% decline from fiscal 2015.
- Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2015 was $6.49M, a 81.61% increase from fiscal 2014.
- Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2014 was $3.58M, a 50.91% increase from fiscal 2013.
- Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2013 was $2.37M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2017-09-30 | $90.82K 10-Q · filed 2017-11-14 | $974.16K derived: sum of 2 quarters · filed 2017-11-14 | $2.12M 10-Q · filed 2017-11-14 | $3.25M derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | $883.34K 10-Q · filed 2017-08-14 | $2.03M 10-Q · filed 2017-08-14 | $3.16M derived: sum of 3 quarters · filed 2017-08-14 | $4.18M derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-03-31 | $1.15M 10-Q · filed 2017-05-22 | $2.27M derived: sum of 2 quarters · filed 2017-05-22 | $3.30M derived: sum of 3 quarters · filed 2017-11-14 | $4.54M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $2.15M derived: sum of 2 quarters · filed 2017-11-14 | $3.40M derived: sum of 3 quarters · filed 2017-11-14 | $4.87M 10-K · filed 2017-03-28 |
| 2016-09-30 | $1.03M 10-Q · filed 2017-11-14 | $2.27M derived: sum of 2 quarters · filed 2017-11-14 | $3.74M 10-Q · filed 2017-11-14 | $5.40M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $1.24M 10-Q · filed 2017-08-14 | $2.71M 10-Q · filed 2017-08-14 | $4.37M derived: sum of 3 quarters · filed 2017-08-14 | $6.17M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $1.47M 10-Q · filed 2017-05-22 | $3.13M derived: sum of 2 quarters · filed 2017-05-22 | $4.93M derived: sum of 3 quarters · filed 2017-05-22 | $6.73M derived: sum of 4 quarters · filed 2017-05-22 |
| 2015-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $3.46M derived: sum of 2 quarters · filed 2017-03-28 | $5.26M derived: sum of 3 quarters · filed 2017-03-28 | $6.49M 10-K · filed 2017-03-28 |
| 2015-09-30 | $1.80M 10-Q · filed 2016-11-10 | $3.60M derived: sum of 2 quarters · filed 2016-11-10 | $4.83M 10-Q · filed 2016-11-10 | $5.87M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $1.81M 10-Q · filed 2016-08-12 | $3.04M 10-Q · filed 2016-08-12 | $4.08M derived: sum of 3 quarters · filed 2016-08-12 | $5.13M derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $1.23M 10-Q · filed 2016-05-13 | $2.27M derived: sum of 2 quarters · filed 2016-05-13 | $3.33M derived: sum of 3 quarters · filed 2016-05-13 | $4.12M derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $2.10M derived: sum of 2 quarters · filed 2016-03-30 | $2.89M derived: sum of 3 quarters · filed 2016-03-30 | $3.58M 10-K · filed 2016-03-30 |
| 2014-09-30 | $1.06M 10-Q · filed 2015-11-10 | $1.85M derived: sum of 2 quarters · filed 2015-11-10 | $2.54M 10-Q · filed 2015-11-10 | $3.15M derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $791.11K 10-Q · filed 2015-08-12 | $1.48M 10-Q · filed 2015-08-12 | $2.10M derived: sum of 3 quarters · filed 2015-08-12 | $2.68M derived: sum of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | $685.41K 10-Q · filed 2015-05-15 | $1.31M derived: sum of 2 quarters · filed 2015-05-15 | $1.89M derived: sum of 3 quarters · filed 2015-05-15 | |
| 2013-12-31 | $619.64K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $1.20M derived: sum of 2 quarters · filed 2015-03-19 | $2.37M 10-K · filed 2015-03-19 | |
| 2013-09-30 | $583.37K 10-Q · filed 2014-11-14 | $1.75M 10-Q · filed 2014-11-14 |